AstraZeneca

AstraZeneca’s TAGRISSO Combo Shows Strong Survival Benefit in EGFR-Mutated Lung Cancer

WILMINGTON, DE — AstraZeneca announced that its lung cancer therapy TAGRISSO® (osimertinib), when used in combination with chemotherapy, delivered a statistically significant and clinically meaningful improvement in overall survival for patients …

AstraZeneca’s TAGRISSO Combo Shows Strong Survival Benefit in EGFR-Mutated Lung Cancer Read More

Financial Performance

Burnham Holdings Posts Strong Q2 as Strategic Realignment Boosts Core Boiler Business

LANCASTER, PA  — Burnham Holdings, Inc. (OTC-Pink: BURCA) reported solid second-quarter financial results on Friday, as the company’s ongoing restructuring efforts—including key divestitures and operational streamlining—continued to deliver stronger margins, …

Burnham Holdings Posts Strong Q2 as Strategic Realignment Boosts Core Boiler Business Read More